Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
18.48
+0.65 (3.65%)
Dec 20, 2024, 4:00 PM EST - Market closed
Arvinas Employees
Arvinas had 445 employees as of December 31, 2023. The number of employees increased by 30 or 7.23% compared to the previous year.
Employees
445
Change (1Y)
30
Growth (1Y)
7.23%
Revenue / Employee
$362,022
Profits / Employee
-$693,483
Market Cap
1.27B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Pediatrix Medical Group | 5,450 |
| Myriad Genetics | 2,700 |
| Artivion | 1,500 |
| STAAR Surgical Company | 1,057 |
| Alphatec Holdings | 839 |
| Progyny | 566 |
| Intellia Therapeutics | 526 |
| BioLife Solutions | 414 |
ARVN News
- 11 days ago - Arvinas and Pfizer Announce Initial Phase 1b Data from the TACTIVE-U Sub-Study of Vepdegestrant in Combination with Abemaciclib at 2024 San Antonio Breast Cancer Symposium - GlobeNewsWire
- 17 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Shareholders to Learn More About the Investigation - Accesswire
- 18 days ago - Arvinas, Inc. (ARVN) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Contact the Firm to Learn More About the Investigation - Accesswire
- 19 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Shareholders to Inquire about Securities Investigation - Accesswire
- 20 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Shareholders to Connect - Accesswire
- 22 days ago - Bronstein, Gewirtz & Grossman, LLC Is Investigating Arvinas, Inc. (ARVN) And Encourages Investors to Connect - Accesswire
- 23 days ago - Bronstein, Gewirtz & Grossman, LLC Encourages Arvinas, Inc. (ARVN) Stockholders to Inquire about Securities Investigation - Accesswire
- 24 days ago - Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Arvinas, Inc. (ARVN) and Encourages Investors to Learn More About the Investigation - Accesswire